Elysia Capital

Elysia Capital is an investment firm specializing in impact-driven ventures across diverse sectors. The firm focuses on identifying and supporting ideas, projects, and activities that deliver both financial returns and a positive contribution to society and local communities. Their investment philosophy prioritizes innovation, education, well-being, and cultural initiatives, employing a strategic approach to capital deployment that seeks measurable social and environmental benefits alongside economic growth.

The firm was established in 2018 by co-founders Stefano Buono and Maribel Lopera Sierra. The foundation of Elysia Capital emerged from Lopera Sierra’s prior entrepreneurial success, specifically following the acquisition of her biotech company by Novartis. This experience provided the impetus and financial wherewithal to launch a new entity dedicated to channeling capital into enterprises poised to create significant societal impact, leveraging their collective expertise and vision for sustainable development.

Elysia Capital primarily serves ambitious founders and projects within innovation, education, health, and artistic fields, acting as a financial partner committed to their growth. The firm’s overarching vision is to foster meaningful societal and community advancement by meticulously selecting and nurturing businesses that align with their core values. They aim to cultivate a portfolio of companies actively driving positive change, shaping a more sustainable and equitable future.